SEQUOIATONE-B
Compound with spectra: 1 NMR
| SpectraBase Compound ID | JIdAB0HFRL7 |
|---|---|
| InChI | InChI=1S/C22H30O5/c1-6-7-8-9-10-14(2)19(23)12-17-20(21(24)26-5)16-11-15(3)27-13-18(16)22(17,4)25/h11-14,25H,6-10H2,1-5H3/b17-12-/t14-,22+/m0/s1 |
| InChIKey | AZRKTTNHSKOLMR-YBWKPQSASA-N |
| Mol Weight | 374.48 g/mol |
| Molecular Formula | C22H30O5 |
| Exact Mass | 374.209324 g/mol |
| Enantiomer InChIKey | AZRKTTNHSKOLMR-ZFKUNJMVSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(6E,7S)-7-hydroxy-3,7-dimethyl-6-[(3S)-3-methyl-2-oxononylidene]-1,7a-dihydrocyclopenta[c]pyran-5-carboxylic acid methyl ester
SEQUOIATONE-F
8,8-Dimethyl-8,9-Dihydrospiro[benzo[b]oxepin-6(7H),2'-[1,3]dioxolan]-4,5-dicarboxylic acid-dimethylester
(1R,3S,5r,7r)-1'-isopropyl-5,7-dimethyl-1,3-diazaspiro[adamantane-2,3'-indoline]-2',6-dione
2-Naphthalenol, decahydro-5-(1H-indol-3-ylmethyl)-1,4a-dimethyl-6-methylene-1-(4-methyl-3-pentenyl)-, acetate, (1.alpha.,2.beta.,4a.beta.,5.alpha.,8a.alpha.)-
(25R)-7.alpha.,-26-Dihydroxycholest-4-en-3-one 26-acetate
2-amino-7,7-dimethyl-4-{4-[(4-methylbenzyl)oxy]-3-nitrophenyl}-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile
AXINYSONE_D
(E)-6-[(3S,3aS,5aS,6R,9aS,9bS)-3a,6-dimethyl-3-(2-methyl-1,3-dioxolan-2-yl)spiro[1,2,3,4,5,5a,8,9,9a,9b-decahydrocyclopenta[f]naphthalene-7,2'-1,3-dioxolane]-6-yl]hex-2-enoic acid methyl ester
5H-[1,3]dioxolo[4,5-g]pyrazolo[4,3-c]quinoline, 5-[(4-chlorophenyl)methyl]-3-(4-ethoxyphenyl)-
| Title | Journal or Book | Year |
|---|---|---|
| Sequoiatones A and B: Novel Antitumor Metabolites Isolated from a Redwood Endophyte | The Journal of Organic Chemistry | 1999 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.